Novo Nordisk Named Global Leader in Sustainability

Corporate Knights named Danish pharmaceutical firm Novo Nordisk number one in its eighth annual Global 100 list of the most sustainable large corporations.  In selecting the 2012 Global 100,  Corporate Knights tapped into top sustainability research firms to identify the top 10 percent of 3,500 companies, then ranked these on 11 indicators representing various factors of sustainability:  Energy productivity, carbon productivity, water productivity, waste productivity, leadership diversity, CEO-to-average worker pay, percent of tax paid, safety productivity, sustainability results linked to executive pay, innovation capacity and employee turnover.  Of the companies populating the 2012 Global 100, only eight U.S. companies made the list.  The UK leads with 16 companies on the list, followed by Japan with 11 and France ties the US with eight each.

Novo Nordisk, the world’s largest manufacturer of insulin, excels in areas beyond these 11 indicators.  The company leads the pharmaceutical sector with top quartile performance in energy productivity and pay equity (CEO/average employee pay ratio of 15 versus 93 for the industry) and is the only pharmaceutical company to link CEO pay to corporate sustainability performance.  Believing that access to essential medicines is a human right, Novo Nordisk sells insulin to the poorest 33 countries for 20 percent or less of the average price for developed nations.  The company doesn’t conduct live animal product testing.  The GRI (Global Reporting Index) holds up Novo Nordisk as a model for the quality of its reporting, which has integrated sustainability with the company’s annual report since 2004. 

Novo Nordisk FlexPenWorking with Novo Nordisk as a client, I am impressed by the commitment of their people, the pride they have in their company and how well they have integrated sustainability into their culture and business practices. 

Novo Nordisk layers financial success on top of its sustainability recognition.  The company announced this week that it has raised its 2012 financial guidance on the heels of a 19% increase in fourth-quarter earnings over the prior year.  They continue to achieve outstanding results in the midst of global economic uncertainty, healthcare reform and a struggling pharmaceutical sector.  Novo Nordisk sets a strong example of a company thriving financially, environmentally and socially.  They are doing well by doing good. 

Sources:

Novo Nordisk:  http://www.novonordisk.com/sustainability/news/2011-01-Novo-Nordisk-climbs-global-list-of-100-most-sustainable-companies.asp

Corporate Knights http://www.corporateknights.ca/

Triple Pundit:  http://www.triplepundit.com/2012/02/novo-nordisk-really-sustainable-company-world/

 

 

Home Page Teaser: 
Corporate Knights named Danish pharmaceutical firm Novo Nordisk number one in its eighth annual Global 100 list of the most sustainable large corporations. In selecting the 2012 Global 100, Corporate Knights tapped into top sustainability research firms to identify the top 10 percent of 3,500 companies, then ranked these on 11 indicators representing various factors of sustainability: Energy productivity, carbon productivity, water productivity, waste productivity, leadership diversity, CEO-to-average worker pay, percent of tax paid, safety productivity, sustainability results linked to executive pay, innovation capacity and employee turnover.

Comments

Post new comment

The content of this field is kept private and will not be shown publicly.
Image CAPTCHA
Enter the characters shown in the image.
By submitting this form, you accept the Mollom privacy policy.